UNIVERSITY COLLEGE LONDON
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Private
- Established
- 1826-02-11
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.ucl.ac.uk
The SUMMIT Study: A Cancer Screening Study
Active, not recruiting
- Conditions
- CancerLung Cancer
- Interventions
- Radiation: Low Dose CT scan
- First Posted Date
- 2019-05-02
- Last Posted Date
- 2024-12-05
- Lead Sponsor
- University College, London
- Target Recruit Count
- 13035
- Registration Number
- NCT03934866
- Locations
- 🇬🇧
UCLH, London, United Kingdom
Thirst-guided Subject-controlled Rehydration in Healthy Volunteers
Not Applicable
- Conditions
- Dehydration Hypertonic
- Interventions
- Device: Patient controlled fluid device administering low volume thirst guided fluid bolusDevice: Patient controlled fluid device administering high volume thirst guided fluid bolus
- First Posted Date
- 2019-05-01
- Last Posted Date
- 2019-05-15
- Lead Sponsor
- University College, London
- Target Recruit Count
- 16
- Registration Number
- NCT03932890
- Locations
- 🇬🇧
Department of Sport and Exercise Science, Portsmouth, United Kingdom
Simvastatin in Secondary Progressive Multiple Sclerosis
- First Posted Date
- 2019-03-29
- Last Posted Date
- 2024-01-10
- Lead Sponsor
- University College, London
- Target Recruit Count
- 40
- Registration Number
- NCT03896217
- Locations
- 🇬🇧
Department of Neuroinflammation, UCL Institute of Neurology, London, United Kingdom
Enabling the Study of Metabolism in Breast Cancer Through Collection of Fresh-tissue Biopsies
Not yet recruiting
- Conditions
- Breast Cancer
- Interventions
- Procedure: Research Biopsy
- First Posted Date
- 2019-03-19
- Last Posted Date
- 2019-03-19
- Lead Sponsor
- University College, London
- Target Recruit Count
- 240
- Registration Number
- NCT03880097
A Study of CXD101 in Combination With Pembrolizumab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Phase 1
Withdrawn
- Conditions
- Diffuse Large B Cell Lymphoma
- Interventions
- Combination Product: Pembrolizumab and CXD101
- First Posted Date
- 2019-03-13
- Last Posted Date
- 2021-08-17
- Lead Sponsor
- University College, London
- Registration Number
- NCT03873025
Electrocautery Ablation for the Prevention of Lung Cancer
Phase 2
Terminated
- Conditions
- Lung Cancer Squamous Cell
- Interventions
- Procedure: Electrocautery Ablation (EC)
- First Posted Date
- 2019-03-11
- Last Posted Date
- 2022-10-31
- Lead Sponsor
- University College, London
- Target Recruit Count
- 13
- Registration Number
- NCT03870152
- Locations
- 🇬🇧
UCLH, London, United Kingdom
Prevention of Hypertensive Injury to the Brain by Intensive Treatment of Blood Pressure After Intracerebral Haemorrhage (PROHIBIT-ICH)
Not Applicable
Terminated
- Conditions
- Intracerebral Hemorrhage
- Interventions
- Device: A&D BP Digital Blood Pressure Monitor (UA-767PBT-Ci) CE Declaration UA-767PBT-Ci
- First Posted Date
- 2019-03-05
- Last Posted Date
- 2024-12-10
- Lead Sponsor
- University College, London
- Target Recruit Count
- 86
- Registration Number
- NCT03863665
- Locations
- 🇬🇧
Royal United Hospitals Bath, Bath, United Kingdom
🇬🇧West Suffolk Hospital, Bury St Edmunds, United Kingdom
🇬🇧St George's, London, United Kingdom
The Deep Phenotype of Lamin A/C Cardiomyopathy
Recruiting
- Conditions
- Lamin A/C Gene MutationDilated Cardiomyopathy, Familial
- First Posted Date
- 2019-03-04
- Last Posted Date
- 2019-10-16
- Lead Sponsor
- University College, London
- Target Recruit Count
- 150
- Registration Number
- NCT03860454
- Locations
- 🇬🇧
University Hospital Birmingham (UHB), Birmingham, United Kingdom
🇬🇧Barts Heart Center, St Bartholomew's Hospital NHS Trust, London, United Kingdom
🇬🇧Royal Brompton Hospital NHS Trust (RBHT), London, United Kingdom
Transfer of Effector Memory T Cells (Tem) Following Allogeneic Stem Cell Transplantation
Phase 1
- Conditions
- Myelodysplastic SyndromesGraft Vs Host DiseaseSevere Aplastic AnemiaLymphomaMyelomaLeukemiaPrimary Immune Deficiency
- Interventions
- Biological: CD62L- Tem
- First Posted Date
- 2019-02-11
- Last Posted Date
- 2019-10-25
- Lead Sponsor
- University College, London
- Target Recruit Count
- 18
- Registration Number
- NCT03836690
- Locations
- 🇬🇧
UCLH, London, United Kingdom
The United Kingdom Thrombotic Thrombocytopenic Purpura Registry (UK TTP Registry)
- Conditions
- TTP - Thrombotic Thrombocytopenic Purpura
- First Posted Date
- 2019-02-06
- Last Posted Date
- 2019-02-06
- Lead Sponsor
- University College, London
- Target Recruit Count
- 1000
- Registration Number
- NCT03832881
- Locations
- 🇬🇧
University College London Hospital, London, United Kingdom
© Copyright 2025. All Rights Reserved by MedPath